Nav: Home

Aging and cancer: An enzyme protects chromosomes from oxidative damage

December 20, 2016

EPFL scientists have identified a protein that caps chromosomes during cell division and protect them from oxidative damage and shortening, which are associated with aging and cancer.

When cells divide, they pack up all of their genetic material in the tightly wrapped chromosomes. The ends of our chromosomes have a unique structure, named a telomere. Replication of telomeres requires specialized mechanisms, which adult organisms only have in a small number of cells. This means that chromosomes become shorter over time, limiting the lifespan of cells and contributing to aging. Telomeres are also very sensitive to oxidative damage, which affects their ability to replicate. EPFL scientists have now discovered a protein that associates with chromosomes during cell division and protects their tips from oxidative damage. The discovery, published in Cell Reports, could have significant implications for how we could treat cancer and other age-related diseases in the future.

Division, damage, and shortening

Precise transmission of the genome from a cell to its progeny is vital to maintain its characteristics and for the health of the entire organism. Our genome is constantly subjected to damage from environmental factors such as sunlight and oxygen radicals, which are by-products of our normal metabolic functions. As such, oxidative damage is a constant threat to all life on Earth.

Cells have evolved numerous antioxidative defenses, but some parts of the cell, like the chromosome tips, the telomeres, are particularly vulnerable to oxidative damage. Telomeres are sequences of repetitive nucleotides at each end of a chromosome. Their role is to protect that end from damage or from fusing with other chromosomes, which would be catastrophic for the cell. In most adult tissues, every time it divides, its chromosomes shorten a little in length; eventually, the telomeres shorten so much that the end of the chromosome becomes exposed, which causes either the death of the cell or an irreversible block to further divisions. This process is accelerated by oxidative damage. The prevailing theory of aging, as well as cancer, cites a central role for oxidative damage of the telomeres in these processes.

An enzyme that protects telomeres

Chromosomes are made up of DNA that is tightly wound up around specialized proteins. The labs of Joachim Lingner and Viesturs Simanis at EPFL analyzed the protein make-up of telomeres across the entire cell cycle to better understand how oxidative damage affects telomeres during division.

The researchers used a number of molecular biology techniques, including a relatively new one called QTIP, which labels various proteins in chromosomes so that researchers can compare and identify quantitative differences between the protein composition of telomeres in various phases of the life cycle.

The study identified an enzyme called Peroxiredoxin 1 (PRDX1). It functions as an antioxidant enzyme, meaning that it is used by cells to mitigate the effects of oxidative damage.

Using QTIP, the researchers found large amounts of PRDX1 on telomeres during two phases of the cell cycle: the phase when the cells synthesizes new DNA and duplicates its genetic material (S-phase), and during the immediately following phase (G2), when the cell grows in size just before it begins dividing.

Using genetic techniques, the scientist removed PRDX1 from the cells, and found that the telomeres were even more susceptible to oxidative damage. This means that PRDX1 plays an antioxidative role that protects telomeres.

In addition, the researchers were able to shed some light onto how oxidative damage affects telomeres. When they incorporated an oxidatively damaged nucleotide into telomeres, they found that the chromosome stopped growing. The reason is that the enzyme called telomerase that builds chromosomes by elongating them abruptly abandoned the process when it encountered the damaged nucleotide. As cancer cells require telomerase for survival this finding may open up novel avenues for attacking this enzyme in cancer.

"Our study links oxidative damage and telomeres, both of which have been previously linked to aging and cancer," says Joachim Lingner. In addition to these, oxidative damage of telomeres is also connected to cardiac failure and muscular dystrophy. Having identified PRDX1, Lingner's lab will now try to determine if there are other antioxidant enzymes that can protect telomeres: "We expect that further studies of this problem will provide insights that help us understand mechanisms of cancer development, aging and inherited disease."
This study was funded by the Swiss National Science Foundation (SNSF), the NCCR RNA and disease network, the European Commission's Seventh Framework Programme (CodeAge), the Swiss Cancer League and EPFL.


Eric Aeby, Wareed Ahmed, Sophie Redon, Viesturs Simanis, Joachim Lingner. Peroxiredoxin 1 protects telomeres from oxidative damage and preserves telomeric DNA for extension by telomerase. Cell Reports 17, 1¬-8. DOI: 10.1016/j.celrep.2016.11.071

Ecole Polytechnique Fédérale de Lausanne

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...